COVID-19 PRECAUTIONS:    VIEW THE practices Arizona Oncology has implemented to protect our patients and their families.
Blog     Careers     About Us     Bill Pay     Patient Portal     QOPI Re-Certification     

Arizona Oncology Celebrates Advances in Lung Cancer through Community-Based Research


Arizona Oncology Celebrates Advances in Lung Cancer through Community-Based Research

Lung cancer is the number one form of cancer that kills both men and women in the United States. This year alone, more than 224,210 Americans are expected to be diagnosed with the disease, approximately 159,260 people will die.

In August, 2005, The National Cancer Institute (NCI) announced an integrated effort to eliminate the suffering and death due to lung cancer by 2015. As part of this integrated implementation plan, three critical strategies are being targeted: Reducing the risk for lung cancer by achieving more effective tobacco control  Improving the likelihood of a cure through earlier detection and treatment of lung cancer and pre-cancer Introduction of novel targeted therapies through cohesive partnerships with ongoing or planned biology initiatives

Arizona Oncology plays a major role in the battle against lung cancer by providing easy access a full range of advanced cancer care services for patients fighting lung cancer. Our medical and radiation oncologists and their staffs provide chemotherapy, injections, infusion services, radiation therapy and diagnostic imaging services in a setting that allows patients to remain close to their homes and their support network of family and friends. As a result, patients access the best possible treatment with the least amount of disruption to their daily lives.

Through its affiliation with, one of the nation largest healthcare services networks dedicated exclusively to cancer treatment and research, Arizona Oncology also brings opportunities to participate in the ongoing clinical research and development of the newest promising cancer therapies to patients throughout Arizona.

"Clinical trial availability is critical for cancer researchers and patients alike," adds Dr. Michael Roberts, medical oncologist at Arizona Oncology. "Because of the vast number of trials under way at any one time, there is a great need for patients who meet participation criteria. Community-based oncology centers, such as ours, play a major role in identifying patients who qualify, while also extending the reach of promising investigational therapies to more patients."

To learn more about lung cancer prevention, treatment and clinical trials at Arizona Oncology, visit or call 888-972-CURE.

About Arizona Oncology Arizona Oncology is one of the largest medical groups in Arizona, with more than 60 practicing physicians devoted exclusively to the most comprehensive, compassionate and quality cancer care to patients in several communities throughout the state, including: Chandler, Cottonwood, Deer Valley, Flagstaff, Glendale, Green Valley, Nogales, Oro Valley, Phoenix, Prescott Valley, Safford, Scottsdale, Sedona, and Tucson. Arizona Oncology believes it is beneficial to provide cancer therapies in a community setting, close to patients' homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit Arizona Oncology is united in healing with The US Oncology Network, one of the nations largest networks of integrated community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, Arizona Oncology is united with nearly 1,000 physicians nationwide. Arizona Oncology participates in clinical trials through US Oncology Research, which has played a role in 48 FDA-approved cancer therapies, nearly 1/3 of all cancer therapies approved by the FDA to date. For more information, visit


AZ Oncology

Subscribe to the latest in cancer news — delivered to your inbox.